Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
SALMETEROL XINAFOATE
(1994)
Small molecule
Beta-2 adrenergic receptor agonist
Unknown
Approved
Asthma; Asthma, Exercise-Induced; Bronchial Spasm; Bronchitis, Chronic; Emphysema; Pulmonary Disease, Chronic Obstructive
SALMETEROL XINAFOATE
×
Maximum Phase:
4
First Approval:
1994
UNII:
6EW8Q962A5
Molecule Type:
Small molecule
Molecular Formula:
C36H45NO7
Molecular Weight:
603.76
AlogP:
4.11
PSA:
81.95
HBD:
4.0
HBA:
#RotB:
16.0
Source:
ACRIVASTINE
(1994)
Small molecule
Histamine H1 receptor antagonist
Unknown
Approved
Hypersensitivity
ACRIVASTINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
A20F9XAI7W
Molecule Type:
Small molecule
Molecular Formula:
C22H24N2O2
Molecular Weight:
348.45
AlogP:
4.02
PSA:
53.43
HBD:
1.0
HBA:
#RotB:
6.0
Source:
IOBENGUANE
(1994)
Small molecule
Unknown
Unknown
Approved
Unknown
IOBENGUANE
×
Maximum Phase:
4
First Approval:
1994
UNII:
35MRW7B4AD
Molecule Type:
Small molecule
Molecular Formula:
C8H10IN3
Molecular Weight:
275.09
AlogP:
1.27
PSA:
61.9
HBD:
3.0
HBA:
#RotB:
2.0
Source:
PHENIRAMINE
(1994)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity; Pruritus
PHENIRAMINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
134FM9ZZ6M
Molecule Type:
Small molecule
Molecular Formula:
C16H20N2
Molecular Weight:
240.35
AlogP:
3.17
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
5.0
Source:
LAMOTRIGINE
(1994)
Small molecule
Sodium channel alpha subunit blocker
ORAL
Approved
Bipolar Disorder; Depressive Disorder; Epilepsies, Partial; Epilepsy; Epilepsy, Tonic-Clonic; Lennox Gastaut Syndrome; Seizures
LAMOTRIGINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
U3H27498KS
Molecule Type:
Small molecule
Molecular Formula:
C9H7Cl2N5
Molecular Weight:
256.1
AlogP:
2.01
PSA:
90.71
HBD:
2.0
HBA:
#RotB:
1.0
Source:
FLUVOXAMINE
(1994)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
FLUVOXAMINE
×
Maximum Phase:
4
First Approval:
1994
UNII:
O4L1XPO44W
Molecule Type:
Small molecule
Molecular Formula:
C15H21F3N2O2
Molecular Weight:
318.34
AlogP:
3.2
PSA:
56.84
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TACROLIMUS
(1994)
Small molecule
FK506-binding protein 1A inhibitor
INJECTION; ORAL; TOPICAL
Approved
Eczema; Immune System Diseases
TACROLIMUS
×
Maximum Phase:
4
First Approval:
1994
UNII:
WM0HAQ4WNM
Molecule Type:
Small molecule
Molecular Formula:
C44H69NO12
Molecular Weight:
804.03
AlogP:
4.64
PSA:
178.36
HBD:
3.0
HBA:
#RotB:
7.0
Source:
BUDESONIDE
(1994)
Small molecule
Glucocorticoid receptor agonist
INHALATION; NASAL; ORAL; RECTAL
Approved
Asthma; Bronchitis, Chronic; Colitis, Ulcerative; Crohn Disease; Emphysema; Lung Diseases, Obstructive; Nasal Obstruction; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
BUDESONIDE
×
Maximum Phase:
4
First Approval:
1994
UNII:
Q3OKS62Q6X
Molecule Type:
Small molecule
Molecular Formula:
C25H34O6
Molecular Weight:
430.54
AlogP:
2.72
PSA:
93.06
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NEFAZODONE HYDROCHLORIDE
(1994)
Small molecule
Norepinephrine transporter inhibitor
ORAL
Approved
Depression; Depressive Disorder, Major
NEFAZODONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1994
UNII:
27X63J94GR
Molecule Type:
Small molecule
Molecular Formula:
C25H33Cl2N5O2
Molecular Weight:
506.48
AlogP:
3.55
PSA:
55.53
HBD:
0.0
HBA:
#RotB:
10.0
Source:
NALMEFENE
(1995)
Small molecule
Unknown
Unknown
Approved
Alcoholism
NALMEFENE
×
Maximum Phase:
4
First Approval:
1995
UNII:
TOV02TDP9I
Molecule Type:
Small molecule
Molecular Formula:
C21H25NO3
Molecular Weight:
339.44
AlogP:
2.51
PSA:
52.93
HBD:
2.0
HBA:
#RotB:
2.0
Source:
CISATRACURIUM BESYLATE
(1995)
Small molecule
Muscle-type nicotinic acetylcholine receptor antagonist
INJECTION
Approved
Unknown
CISATRACURIUM BESYLATE
×
Maximum Phase:
4
First Approval:
1995
UNII:
80YS8O1MBS
Molecule Type:
Small molecule
Molecular Formula:
C65H82N2O18S2
Molecular Weight:
1243.5
AlogP:
8.07
PSA:
126.44
HBD:
0.0
HBA:
#RotB:
24.0
Source:
IBUTILIDE
(1995)
Small molecule
Unknown
Unknown
Approved
Arrhythmias, Cardiac
IBUTILIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
2436VX1U9B
Molecule Type:
Small molecule
Molecular Formula:
C20H36N2O3S
Molecular Weight:
384.59
AlogP:
4.16
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
14.0
Source:
MOEXIPRIL
(1995)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
MOEXIPRIL
×
Maximum Phase:
4
First Approval:
1995
UNII:
WT87C52TJZ
Molecule Type:
Small molecule
Molecular Formula:
C27H34N2O7
Molecular Weight:
498.58
AlogP:
2.58
PSA:
114.4
HBD:
2.0
HBA:
#RotB:
11.0
Source:
NALMEFENE HYDROCHLORIDE
(1995)
Small molecule
Opioid receptors; mu/kappa/delta antagonist
Unknown
Approved
Unknown
NALMEFENE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
K7K69QC05X
Molecule Type:
Small molecule
Molecular Formula:
C21H26ClNO3
Molecular Weight:
375.9
AlogP:
2.51
PSA:
52.93
HBD:
2.0
HBA:
#RotB:
2.0
Source:
DEXRAZOXANE
(1995)
Small molecule
DNA topoisomerase II inhibitor
Unknown
Approved
Unknown
DEXRAZOXANE
×
Maximum Phase:
4
First Approval:
1995
UNII:
048L81261F
Molecule Type:
Small molecule
Molecular Formula:
C11H16N4O4
Molecular Weight:
268.27
AlogP:
-2.71
PSA:
98.82
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MYCOPHENOLATE MOFETIL
(1995)
Small molecule
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
ORAL
Approved
Unknown
MYCOPHENOLATE MOFETIL
×
Maximum Phase:
4
First Approval:
1995
UNII:
9242ECW6R0
Molecule Type:
Small molecule
Molecular Formula:
C23H31NO7
Molecular Weight:
433.5
AlogP:
2.52
PSA:
94.53
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TRIMETHOPRIM HYDROCHLORIDE
(1995)
Small molecule
Bacterial dihydrofolate reductase inhibitor
ORAL
Approved
Unknown
TRIMETHOPRIM HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
9XE000OU9B
Molecule Type:
Small molecule
Molecular Formula:
C14H19ClN4O3
Molecular Weight:
326.78
AlogP:
1.26
PSA:
105.51
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NISOLDIPINE
(1995)
Small molecule
Voltage-gated L-type calcium channel blocker
ORAL
Approved
Cardiovascular Diseases; Hypertension
NISOLDIPINE
×
Maximum Phase:
4
First Approval:
1995
UNII:
4I8HAB65SZ
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2O6
Molecular Weight:
388.42
AlogP:
3.2
PSA:
107.77
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CETIRIZINE
(1995)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations; Hypersensitivity
CETIRIZINE
×
Maximum Phase:
4
First Approval:
1995
UNII:
YO7261ME24
Molecule Type:
Small molecule
Molecular Formula:
C21H25ClN2O3
Molecular Weight:
388.9
AlogP:
3.15
PSA:
53.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CETIRIZINE HYDROCHLORIDE
(1995)
Small molecule
Histamine H1 receptor antagonist
INJECTION; OPHTHALMIC; ORAL
Approved
Rhinitis, Allergic, Seasonal; Urticaria
CETIRIZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
64O047KTOA
Molecule Type:
Small molecule
Molecular Formula:
C21H27Cl3N2O3
Molecular Weight:
461.82
AlogP:
3.15
PSA:
53.01
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CEFTIBUTEN
(1995)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Approved
Bacterial Infections; Bronchitis, Chronic; Otitis Media
CEFTIBUTEN
×
Maximum Phase:
4
First Approval:
1995
UNII:
IW71N46B4Y
Molecule Type:
Small molecule
Molecular Formula:
C15H14N4O6S2
Molecular Weight:
410.43
AlogP:
-0.05
PSA:
162.92
HBD:
4.0
HBA:
#RotB:
6.0
Source:
GLIMEPIRIDE
(1995)
Small molecule
Sulfonylurea receptor 1, Kir6.2 blocker
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
GLIMEPIRIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
6KY687524K
Molecule Type:
Small molecule
Molecular Formula:
C24H34N4O5S
Molecular Weight:
490.63
AlogP:
3.07
PSA:
124.68
HBD:
3.0
HBA:
#RotB:
7.0
Source:
TRAMADOL
(1995)
Small molecule
Unknown
Unknown
Approved
Pain
TRAMADOL
×
Maximum Phase:
4
First Approval:
1995
UNII:
39J1LGJ30J
Molecule Type:
Small molecule
Molecular Formula:
C16H25NO2
Molecular Weight:
263.38
AlogP:
2.63
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MOEXIPRIL HYDROCHLORIDE
(1995)
Small molecule
Angiotensin-converting enzyme inhibitor
Unknown
Approved
Hypertension
MOEXIPRIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
Q1UMG3UH45
Molecule Type:
Small molecule
Molecular Formula:
C27H35ClN2O7
Molecular Weight:
535.04
AlogP:
2.58
PSA:
114.4
HBD:
2.0
HBA:
#RotB:
11.0
Source:
PORFIMER SODIUM
(1995)
Small molecule
DNA inhibitor
Unknown
Approved
Unknown
PORFIMER SODIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
Y3834SIK5F
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRAMADOL HYDROCHLORIDE
(1995)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Acute Pain; Chronic Pain; Pain; Substance-Related Disorders
TRAMADOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
9N7R477WCK
Molecule Type:
Small molecule
Molecular Formula:
C16H26ClNO2
Molecular Weight:
299.84
AlogP:
2.63
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ANASTROZOLE
(1995)
Small molecule
Cytochrome P450 19A1 inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
ANASTROZOLE
×
Maximum Phase:
4
First Approval:
1995
UNII:
2Z07MYW1AZ
Molecule Type:
Small molecule
Molecular Formula:
C17H19N5
Molecular Weight:
293.37
AlogP:
2.93
PSA:
78.29
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MUPIROCIN CALCIUM
(1995)
Small molecule
Isoleucyl-tRNA synthetase inhibitor
NASAL; TOPICAL
Approved
Infections
MUPIROCIN CALCIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
RG38I2P540
Molecule Type:
Small molecule
Molecular Formula:
C52H90CaO20
Molecular Weight:
1075.35
AlogP:
2.59
PSA:
146.05
HBD:
4.0
HBA:
#RotB:
16.0
Source:
METFORMIN
(1995)
Small molecule
Unknown
Unknown
Approved
Diabetes Mellitus
METFORMIN
×
Maximum Phase:
4
First Approval:
1995
UNII:
9100L32L2N
Molecule Type:
Small molecule
Molecular Formula:
C4H11N5
Molecular Weight:
129.17
AlogP:
-1.03
PSA:
88.99
HBD:
4.0
HBA:
#RotB:
0.0
Source:
CISATRACURIUM
(1995)
Small molecule
Unknown
Unknown
Approved
Unknown
CISATRACURIUM
×
Maximum Phase:
4
First Approval:
1995
UNII:
QX62KLI41N
Molecule Type:
Small molecule
Molecular Formula:
C53H72N2O12+2
Molecular Weight:
929.16
AlogP:
8.07
PSA:
126.44
HBD:
0.0
HBA:
#RotB:
24.0
Source:
CARVEDILOL
(1995)
Small molecule
Adrenergic receptor alpha-1 antagonist
ORAL
Approved
Cardiovascular Diseases; Heart Failure; Hypertension; Myocardial Infarction; Ventricular Dysfunction, Left
CARVEDILOL
×
Maximum Phase:
4
First Approval:
1995
UNII:
0K47UL67F2
Molecule Type:
Small molecule
Molecular Formula:
C24H26N2O4
Molecular Weight:
406.48
AlogP:
3.74
PSA:
75.74
HBD:
3.0
HBA:
#RotB:
10.0
Source:
LOSARTAN
(1995)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
LOSARTAN
×
Maximum Phase:
4
First Approval:
1995
UNII:
JMS50MPO89
Molecule Type:
Small molecule
Molecular Formula:
C22H23ClN6O
Molecular Weight:
422.92
AlogP:
4.27
PSA:
92.51
HBD:
2.0
HBA:
#RotB:
8.0
Source:
AZELAIC ACID
(1995)
Small molecule
Unknown
TOPICAL
Approved
Acne Vulgaris; Erythema; Rosacea
AZELAIC ACID
×
Maximum Phase:
4
First Approval:
1995
UNII:
F2VW3D43YT
Molecule Type:
Small molecule
Molecular Formula:
C9H16O4
Molecular Weight:
188.22
AlogP:
1.89
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
8.0
Source:
DIRITHROMYCIN
(1995)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Bacterial Infections
DIRITHROMYCIN
×
Maximum Phase:
4
First Approval:
1995
UNII:
1801D76STL
Molecule Type:
Small molecule
Molecular Formula:
C42H78N2O14
Molecular Weight:
835.09
AlogP:
2.2
PSA:
196.33
HBD:
5.0
HBA:
#RotB:
12.0
Source:
SAQUINAVIR
(1995)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
HIV Infections; Virus Diseases
SAQUINAVIR
×
Maximum Phase:
4
First Approval:
1995
UNII:
L3JE09KZ2F
Molecule Type:
Small molecule
Molecular Formula:
C38H50N6O5
Molecular Weight:
670.86
AlogP:
3.09
PSA:
166.75
HBD:
5.0
HBA:
#RotB:
12.0
Source:
BICALUTAMIDE
(1995)
Small molecule
Androgen Receptor antagonist
ORAL
Approved
Carcinoma; Neoplasms
BICALUTAMIDE
×
Maximum Phase:
4
First Approval:
1995
UNII:
A0Z3NAU9DP
Molecule Type:
Small molecule
Molecular Formula:
C18H14F4N2O4S
Molecular Weight:
430.38
AlogP:
2.88
PSA:
107.26
HBD:
2.0
HBA:
#RotB:
5.0
Source:
1
2
…
42
43
44
45
46
47
48
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA